• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Centene Could Decline Further as Broader Market Weakens

Let's check the charts of the health plan provider.
By BRUCE KAMICH
Oct 28, 2020 | 09:10 AM EDT
Stocks quotes in this article: CNC

For his second "Executive Decision" segment of Mad Money Tuesday evening, Jim Cramer spoke with Michael Neidorff, chairman, president and CEO of health plan provider Centene (CNC) , which announced a $275 million charitable donation to its foundation, which will support medical research and give away $15 million a year.

Neidorff said medical research is important, which is why Centene is working with the Mayo Clinic to help develop diagnostic tests for pancreatic cancer, so patients can be diagnosed sooner and have better outcomes.

When asked about the fate of the Affordable Care Act, Neidorff said that Centene stays nimble so they can adapt to tomorrow. He said Centene has great health plans and welcomes competition. 

Let's check if the charts are competitive. 

In the daily bar chart of CNC, below, we can see that prices tested the 50-day moving average line and the 200-day moving average line Tuesday. Prices have had a hard time at the $68 level or area for several months -- a rally failed there in January and July and this month too.

The On-Balance-Volume (OBV) line has been stalled since April and has not shown upside leadership. Sometimes the OBV line can lead prices and break out on the upside before price. Not in this example.

The Moving Average Convergence Divergence (MACD) oscillator crossed above the zero line earlier this month for a buy signal but has quickly narrowed and is poised to cross to the downside. 

 
In the weekly bar chart of CNC, below, we can see that prices are testing the flat 40-week moving average line. The weekly OBV line shows a decline into September and a slight rise into October telling us that sellers have largely dominated.
 
The weekly MACD oscillator has been weakening since February and diverged bearishly from the price action in May. We can see a sell signal in September and then a minor bounce. 
 
 
 
In this daily Point and Figure chart of CNC, below, we can see a potential downside price target in the $54 area.  
 
 
 
Bottom-line strategy: Stand aside on CNC as its charts suggest weakness in the weeks ahead.
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Healthcare | Mad Money | Executive Interview

More from Stocks

Melvin Capital's Demise Presents a Beauty of an Opportunity

Brad Ginesin
May 22, 2022 1:20 PM EDT

The top holder in several companies, the hedge fund's abrupt liquidation has contributed to weakness.

I'm Organizing a Bottom-Fishing Expedition

Bret Jensen
May 22, 2022 11:00 AM EDT

It is easy to see the value of this retail play.

Here's the Secret to Market Timing

James "Rev Shark" DePorre
May 21, 2022 10:00 AM EDT

You've probably been told timing the market is futile, but here's a way to make it possible -- if you're willing to do the work.

It's Official: That Hairy Animal With Claws and Sharp Teeth Is a Bear

James "Rev Shark" DePorre
May 20, 2022 4:31 PM EDT

Along with the media proclamation of a bear market, we have some improvement in the charts of many smaller stocks, but ...

Applied Materials Slips on Miss: Where Will the Chips May Fall

Bruce Kamich
May 20, 2022 1:00 PM EDT

Let's see what the charts say.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:24 PM EDT PAUL PRICE

    An interesting chart

    I'm betting heavily that stocks will be way up aga...
  • 10:10 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "Market Timing for Dummies"
  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login